Biomodex Pharmaceuticals Private Limited
About Biomodex Pharmaceuticals Private Limited
Data last updated:
Biomodex Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2019PTC348128. Its GSTIN is 07AAICB3704D1Z4 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Keshri Kant Mishra and Gayatri Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plotno:1 Flat No: 4 S/F Sultanpur, New Delhi, Delhi, India – 110030.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.02 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹3.56 Lakh (net margin 0.9%) and EBITDA of ₹12.77 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 60% over three years.
Company details
Contact details
Biomodex Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlotno:1 Flat No: 4 S/F Sultanpur, New Delhi, Delhi, India – 110030
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Biomodex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biomodex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biomodex Pharmaceuticals Private Limited, buy the company report.
Financials of Biomodex Pharmaceuticals Private Limited
FY 2025 filings availableBiomodex Pharmaceuticals Private Limited reported revenue of ₹4.02 Cr (up 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 60% over three years, including 39% growth in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biomodex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Biomodex Pharmaceuticals Private Limited
Biomodex Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Keshri Kant Mishra Also directs: Parnasa Mediworld Private Limited | Director | 01 Apr 2019 | 7 Years 6 Months | Current |
| Gayatri Mishra | Director | 01 Apr 2019 | 7 Years 6 Months | Current |
Peer comparison
Biomodex Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tabilac Pharmaceuticals Private Limited | ₹4.06 Cr (FY 2024) | 1213.0% | Sonipat, Haryana, India | |||
| Biomodex Pharmaceuticals Private Limitedthis company | ₹4.02 Cr (FY 2025) | ₹3.56 Lakh | 0.9% | 39.0% | New Delhi, Delhi, India | |
| Chiron Pharmaceuticals Private Limited | ₹4 Cr (FY 2024) | 11.0% | Chennai, Tamil Nadu, India | |||
| Astraazin Pharmaceuticals Private Limited | ₹4 Cr (FY 2025) | -6.0% | New Delhi, Delhi, India |
To see the full peer comparison of Biomodex Pharmaceuticals Private Limited, buy the company report.
Auditor
Biomodex Pharmaceuticals Private Limited is audited by RAJEEV KIRTI & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJEEV KIRTI & CO | FY 2020 | 016132N |
Shareholding
The shareholding of Biomodex Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Biomodex Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biomodex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biomodex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biomodex Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICB3704D1Z4 | Delhi | Active | 25 May 2019 |
To see the full GST registrations and return filing status of Biomodex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Biomodex Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Gayatri Mishra was appointed as Director on 01 Apr 2019.
Frequently asked questions
Biomodex Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 April 2019 (7+ years old) and is registered under CIN U24290DL2019PTC348128.
Biomodex Pharmaceuticals has 2 current directors:
- Keshri Kant Mishra - Director
- Gayatri Mishra - Director
The latest financial statements of Biomodex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Biomodex Pharmaceuticals is 07AAICB3704D1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Biomodex Pharmaceuticals is U24290DL2019PTC348128. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biomodex Pharmaceuticals was incorporated on 01 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Biomodex Pharmaceuticals by revenue are Tabilac Pharmaceuticals Private Limited, Chiron Pharmaceuticals Private Limited, Astraazin Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Gayatri Mishra was appointed as Director on 01 Apr 2019. Keshri Kant Mishra was appointed as Director on 01 Apr 2019.
The registered office of Biomodex Pharmaceuticals is at Plotno:1 Flat No: 4 SF Sultanpur, New Delhi, Delhi, India – 110030.
Biomodex Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Biomodex Pharmaceuticals can be reached at its registered office: Plotno:1 Flat No: 4 SF Sultanpur, New Delhi, Delhi, India – 110030.